rTMS Study Tracking

This report tracks recruitment, assessment completion and clinical scores for RMA01, a study of repetitive transcranial magnetic stimulation (rTMS) for depression in young adults with autism. REDCap data are pulled when the report is built; NIH Toolbox scores and MRI quality metrics come from local exports.

Test records, one duplicate record and one participant who was never allocated to treatment are left out of every summary. Score values that fail the range checks are left out and listed under Data Quality at the end.

For questions about the methods or code, contact Hassan Abdulrasul (hassan.abdulrasul@camh.ca).

Recruitment

Assessment Completion Status

Each heatmap shows one visit: only the forms given at that visit, and only participants who have reached it. Green = completed, gold = partly completed, red = recorded as not completed, grey = nothing entered. Hover over a cell for the recorded answer and the reason a form was not completed. Forms with an old and a new version (HRSD-17, ADOS-2, Pre- and Post-rTMS questionnaires) share one column showing the more complete of the two; the hover lists both. Self-report forms only have REDCap’s own status: “Incomplete” is shown as gold when the form has some answers and grey when it was never opened. Dates, rater and data-entry details, calculated scores and unticked checkboxes don’t count as answers.

Screening

All participants

Baseline MRI

Treatment 1

2 Weeks Post Screening

Treatment

Attendance

Whether treatment was given at each of the 30 sessions (Treatment Log), for every participant who has started treatment.

Session 5

Session 10

Session 15

Session 20

Session 25

Session 30

Post-treatment

1 Week

4 Weeks

12 Weeks

MRI

MRI Visit 1

MRI Visit 2

Demographics

Baseline characteristics Started treatment: attended the first treatment session. Completed treatment: the completers used for the plots over time (12-weeks was captured by using RRS scores at 12 weeks), all of whom started treatment. Complete cohort: the same table for everyone consented. Everything is from the screening visit. Mean (SD) for scores, n (%) for counts; percentages are of participants with a value, and missing values are listed under each table.

Table 1 (manuscript)

Table 1
Baseline demographic and clinical characteristics
	Started treatment (n=26)	Completed treatment (n=17)
Demographics
Age, years	23.3 (5.7)	23.3 (6.2)
Sex assigned at birth
Women	11 (42%)	7 (41%)
Men	15 (58%)	10 (59%)
Gender diverse	8 (31%)	4 (24%)
Race
Asian	3 (12%)	1 (6%)
Black	2 (8%)	1 (6%)
Indigenous	1 (4%)	0 (0%)
White	17 (68%)	13 (76%)
Mixed heritage	2 (8%)	2 (12%)
Hispanic or Latino	1 (4%)	1 (6%)
Duration of education, years	14.0 (2.9)	13.4 (3.0)
In current employment	6 (23%)	3 (18%)
Autism and cognition
Full-scale IQ (WASI-II)	118.2 (14.0)	116.4 (12.6)
ADOS-2 classification
Autism	15 (83%)	10 (91%)
Non-spectrum	3 (17%)	1 (9%)
ADOS-2 calibrated severity score	6.0 (2.5)	5.9 (2.2)
SRS-SF total, self-report	29.2 (8.7)	28.4 (8.0)
SRS-SF total, informant	20.2 (13.2)	21.2 (12.3)
Vineland adaptive behaviour composite	72.1 (15.7)	74.6 (18.0)
Baseline symptom severity
HRSD-17	16.1 (5.9)	14.8 (5.9)
QIDS-SR16	15.9 (5.1)	15.7 (5.2)
MM-PHQ-9	16.6 (5.7)	16.2 (6.6)
BDI-II	29.2 (13.0)	30.7 (10.5)
GAD-7	10.4 (4.4)	9.7 (4.0)
CGI-S (clinician)	4.4 (0.5)	4.3 (0.5)
CGI-S (research assistant)	4.1 (0.6)	4.1 (0.6)
GAF	54.3 (6.0)	54.9 (7.4)
Suicidality
BSS (Beck Scale for Suicide Ideation)	5.7 (5.5)	6.7 (4.9)
C-SSRS most severe ideation, past month
No ideation	10 (43%)	7 (47%)
1 - Wish to be dead	3 (13%)	2 (13%)
2 - Non-specific Active Suicidal Thoughts	4 (17%)	1 (7%)
3 - Active Ideation w/o Plan or Intent	5 (22%)	4 (27%)
4 - Active Ideation w/ Intent, No Plan	1 (4%)	1 (7%)
C-SSRS ideation frequency, past month
No ideation	10 (43%)	7 (47%)
1 - Less than once a week	3 (13%)	1 (7%)
2 - Once a week	2 (9%)	2 (13%)
3 - 2-5 times per week	3 (13%)	2 (13%)
4 - Daily or almost daily	4 (17%)	2 (13%)
5 - Many times a day	1 (4%)	1 (7%)
Previous suicide attempt (C-SSRS, lifetime)	8 (35%)	5 (33%)
SBQ-R total	10.8 (4.3)	11.2 (4.4)
Current SCID-5 diagnoses
Major depressive disorder	12 (50%)	10 (62%)
Persistent depressive disorder	6 (25%)	2 (12%)
Any anxiety disorder	12 (50%)	7 (44%)
Treatment in the current depressive episode (ATHF)
ATHF score	2.4 (2.9)	2.8 (2.9)
Adequate trials (ATHF score ≥ 3)
None	13 (52%)	7 (44%)
One	9 (36%)	7 (44%)
Two	3 (12%)	2 (12%)
Three or more	0 (0%)	0 (0%)
Electroconvulsive therapy	0 (0%)	0 (0%)
Psychotherapy	6 (24%)	6 (38%)
Pharmacotherapy at baseline
Benzodiazepine	3 (12%)	1 (6%)
Antidepressant	17 (68%)	14 (88%)
Antidepressant combination	3 (12%)	2 (12%)
Antipsychotic augmentation	5 (20%)	3 (19%)
Lithium augmentation	0 (0%)	0 (0%)
WASI-II = Wechsler Abbreviated Scale of Intelligence. ADOS-2 = Autism Diagnostic Observation Schedule (calibrated severity 1-10, from the current form only). SRS-SF = Social Responsiveness Scale, short form. HRSD-17 = Hamilton Rating Scale for Depression (v2 form where both versions exist). QIDS-SR16 = Quick Inventory of Depressive Symptomatology, self-report, scored from its 16 items. MM-PHQ-9 = modified Patient Health Questionnaire-9. GAD-7 = Generalized Anxiety Disorder-7. BSS = Beck Scale for Suicide Ideation. CGI-S = Clinical Global Impression, severity, rated by the study clinician and separately by a research assistant (0 = not assessed is treated as missing). BDI-II = Beck Depression Inventory. GAF = Global Assessment of Functioning. C-SSRS = Columbia Suicide Severity Rating Scale (past-month ideation is asked only after a Yes to wish to be dead or suicidal thoughts; both No = no ideation). SBQ-R = Suicidal Behaviors Questionnaire-Revised (3-18). ATHF = Antidepressant Treatment History Form, covering the current depressive episode only; adequate trial = ATHF score of 3 or more (dose and duration), any trial type (medication, augmentation, ECT, rTMS, psychotherapy). The form records adequacy, not response, so trials are adequate, not necessarily failed. SCID = Structured Clinical Interview for DSM-5 (current = meets criteria now). Scores outside their valid range are left out (see Data Quality). Women / men: sex assigned at birth. Gender diverse: a gender identity other than man or woman (trans man, trans woman, two-spirit, non-binary, other), or man / woman different from sex at birth; intersex and “do not know” are not counted. Race: self-reported (check all that apply), grouped as in the race plot; more than one group ticked is shown as such. Employment: full- or part-time paid work. ADOS-2 classification: the current form offers Autism or Non-spectrum only; older forms recorded it as text. Previous suicide attempt: C-SSRS lifetime actual attempt (participants with no lifetime or past-month ideation count as no attempt). SCID depressive disorder is a single choice in REDCap, so MDD and PDD cannot both be recorded. Medications: psychotropic medication record at screening, drugs not marked as stopped; augmentation = with at least one antidepressant. Not available in REDCap: age of onset, handedness, IDS-30, current episode duration. Missing (started treatment / completed treatment): Race 1 / 0; Full-scale IQ (WASI-II) 4 / 3; ADOS-2 classification 8 / 6; ADOS-2 calibrated severity score 13 / 10; SRS-SF total, self-report 2 / 0; SRS-SF total, informant 2 / 0; Vineland adaptive behaviour composite 9 / 6; QIDS-SR16 2 / 0; MM-PHQ-9 13 / 9; GAD-7 5 / 2; CGI-S (clinician) 2 / 2; CGI-S (research assistant) 2 / 2; GAF 2 / 2; BSS (Beck Scale for Suicide Ideation) 5 / 3; C-SSRS most severe ideation, past month 3 / 2; C-SSRS ideation frequency, past month 3 / 2; Previous suicide attempt (C-SSRS, lifetime) 3 / 2; SBQ-R total 2 / 0; Major depressive disorder 2 / 1; Persistent depressive disorder 2 / 1; Any anxiety disorder 2 / 1; ATHF score 1 / 1; Adequate trials (ATHF score ≥ 3) 1 / 1; Electroconvulsive therapy 1 / 1; Psychotherapy 1 / 1; Benzodiazepine 1 / 1; Antidepressant 1 / 1; Antidepressant combination 1 / 1; Antipsychotic augmentation 1 / 1; Lithium augmentation 1 / 1.

Complete cohort

Table 1 for everyone screened, whether or not they went on to treatment.

Table 1
Baseline demographic and clinical characteristics, everyone screened
	All screened (n=45)	Missing, n (%)
Demographics
Age, years	23.9 (5.6)	3 (7%)
Sex assigned at birth		2 (4%)
Women	18 (42%)
Men	25 (58%)
Gender diverse	10 (24%)	3 (7%)
Race		3 (7%)
Asian	5 (12%)
Black	5 (12%)
Indigenous	1 (2%)
Other	1 (2%)
White	26 (62%)
Mixed heritage	2 (5%)
More than one group	2 (5%)
Hispanic or Latino	2 (5%)	3 (7%)
Duration of education, years	14.1 (2.8)	3 (7%)
In current employment	14 (33%)	3 (7%)
Autism and cognition
Full-scale IQ (WASI-II)	118.0 (15.5)	17 (38%)
ADOS-2 classification		22 (49%)
Autism	19 (83%)
Non-spectrum	4 (17%)
ADOS-2 calibrated severity score	5.9 (2.5)	27 (60%)
SRS-SF total, self-report	28.8 (8.4)	10 (22%)
SRS-SF total, informant	16.0 (13.3)	8 (18%)
Vineland adaptive behaviour composite	68.1 (17.6)	22 (49%)
Baseline symptom severity
HRSD-17	13.9 (7.1)	8 (18%)
QIDS-SR16	14.4 (5.1)	11 (24%)
MM-PHQ-9	16.2 (5.3)	27 (60%)
BDI-II	25.4 (14.3)	4 (9%)
GAD-7	10.5 (4.6)	14 (31%)
CGI-S (clinician)	4.2 (0.9)	17 (38%)
CGI-S (research assistant)	4.0 (0.9)	11 (24%)
GAF	54.3 (7.6)	11 (24%)
Suicidality
BSS (Beck Scale for Suicide Ideation)	5.7 (6.1)	16 (36%)
C-SSRS most severe ideation, past month		15 (33%)
No ideation	14 (47%)
1 - Wish to be dead	3 (10%)
2 - Non-specific Active Suicidal Thoughts	6 (20%)
3 - Active Ideation w/o Plan or Intent	6 (20%)
4 - Active Ideation w/ Intent, No Plan	1 (3%)
C-SSRS ideation frequency, past month		15 (33%)
No ideation	14 (47%)
1 - Less than once a week	3 (10%)
2 - Once a week	3 (10%)
3 - 2-5 times per week	4 (13%)
4 - Daily or almost daily	4 (13%)
5 - Many times a day	2 (7%)
Previous suicide attempt (C-SSRS, lifetime)	11 (37%)	15 (33%)
SBQ-R total	10.1 (4.4)	10 (22%)
Current SCID-5 diagnoses
Major depressive disorder	15 (50%)	15 (33%)
Persistent depressive disorder	8 (27%)	15 (33%)
Any anxiety disorder	16 (53%)	15 (33%)
Treatment in the current depressive episode (ATHF)
ATHF score	2.9 (3.2)	8 (18%)
Adequate trials (ATHF score ≥ 3)		8 (18%)
None	17 (46%)
One	13 (35%)
Two	7 (19%)
Three or more	0 (0%)
Electroconvulsive therapy	0 (0%)	8 (18%)
Psychotherapy	6 (16%)	8 (18%)
Pharmacotherapy at baseline
Benzodiazepine	4 (11%)	8 (18%)
Antidepressant	27 (73%)	8 (18%)
Antidepressant combination	5 (14%)	8 (18%)
Antipsychotic augmentation	8 (22%)	8 (18%)
Lithium augmentation	0 (0%)	8 (18%)
WASI-II = Wechsler Abbreviated Scale of Intelligence. ADOS-2 = Autism Diagnostic Observation Schedule (calibrated severity 1-10, from the current form only). SRS-SF = Social Responsiveness Scale, short form. HRSD-17 = Hamilton Rating Scale for Depression (v2 form where both versions exist). QIDS-SR16 = Quick Inventory of Depressive Symptomatology, self-report, scored from its 16 items. MM-PHQ-9 = modified Patient Health Questionnaire-9. GAD-7 = Generalized Anxiety Disorder-7. BSS = Beck Scale for Suicide Ideation. CGI-S = Clinical Global Impression, severity, rated by the study clinician and separately by a research assistant (0 = not assessed is treated as missing). BDI-II = Beck Depression Inventory. GAF = Global Assessment of Functioning. C-SSRS = Columbia Suicide Severity Rating Scale (past-month ideation is asked only after a Yes to wish to be dead or suicidal thoughts; both No = no ideation). SBQ-R = Suicidal Behaviors Questionnaire-Revised (3-18). ATHF = Antidepressant Treatment History Form, covering the current depressive episode only; adequate trial = ATHF score of 3 or more (dose and duration), any trial type (medication, augmentation, ECT, rTMS, psychotherapy). The form records adequacy, not response, so trials are adequate, not necessarily failed. SCID = Structured Clinical Interview for DSM-5 (current = meets criteria now). Scores outside their valid range are left out (see Data Quality). Women / men: sex assigned at birth. Gender diverse: a gender identity other than man or woman (trans man, trans woman, two-spirit, non-binary, other), or man / woman different from sex at birth; intersex and “do not know” are not counted. Race: self-reported (check all that apply), grouped as in the race plot; more than one group ticked is shown as such. Employment: full- or part-time paid work. ADOS-2 classification: the current form offers Autism or Non-spectrum only; older forms recorded it as text. Previous suicide attempt: C-SSRS lifetime actual attempt (participants with no lifetime or past-month ideation count as no attempt). SCID depressive disorder is a single choice in REDCap, so MDD and PDD cannot both be recorded. Medications: psychotropic medication record at screening, drugs not marked as stopped; augmentation = with at least one antidepressant. Not available in REDCap: age of onset, handedness, IDS-30, current episode duration. Missing: participants with no value for that row, as % of everyone screened; percentages in the first column are of participants with a value.

Race and ethnicity

Every race box ticked (check all that apply), as % of participants with a screening visit. Table 1 groups these as set in config/race_categories.csv.

Co-occurring diagnoses

Supplementary table
Co-occurring psychiatric diagnoses (SCID-5-RV) at screening
	Started treatment (n=24 with a SCID)		Completed treatment (n=16 with a SCID)
	Current	Lifetime	Current	Lifetime
Any co-occurring disorder	17 (71%)	19 (79%)	11 (69%)	13 (81%)
Social anxiety disorder (social phobia)	10 (42%)	10 (42%)	5 (31%)	5 (31%)
Attention-deficit/hyperactivity disorder	8 (33%)	8 (33%)	5 (31%)	5 (31%)
Generalized anxiety disorder	6 (25%)	7 (29%)	4 (25%)	5 (31%)
Panic disorder	4 (17%)	5 (21%)	2 (12%)	3 (19%)
Posttraumatic stress disorder	3 (12%)	4 (17%)	2 (12%)	3 (19%)
Other DSM-5 disorder	1 (4%)	2 (8%)	1 (6%)	2 (12%)
Agoraphobia	1 (4%)	1 (4%)	1 (6%)	1 (6%)
Other specified obsessive-compulsive and related disorder	1 (4%)	1 (4%)	1 (6%)	1 (6%)
Specific phobia	1 (4%)	1 (4%)	1 (6%)	1 (6%)
SCID-5-RV at screening, participants with a SCID entered. Current = meets symptomatic criteria now (past month for most disorders); lifetime = lifetime prevalence at threshold. A disorder counts only when its category and the disorder itself are selected. Depressive disorders are in Table 1. Participants can have several disorders.

Other clinical measures

Supplementary table
Other clinical measures at screening
	Started treatment (n=26)	Completed treatment (n=17)
PSQI global score (sleep quality)	8.0 (3.6)	9.0
BRIEF-A Global Executive Composite (T-score)	–	–
RRS brooding	13.9 (3.6)	13.6 (3.7)
RRS reflection	13.0 (3.6)	12.5 (3.5)
PSQI = Pittsburgh Sleep Quality Index (0-21, higher = worse sleep). BRIEF-A = Behavior Rating Inventory of Executive Function, adult (T-score, higher = more difficulty). RRS = Ruminative Response Scale (5-20 each). The GIDYQ-AA (gender identity / dysphoria) has no total score in REDCap and is not shown. Missing (started treatment / completed treatment): PSQI global score (sleep quality) 23 / 16; BRIEF-A Global Executive Composite (T-score) 26 / 17; RRS brooding 5 / 2; RRS reflection 5 / 2.

Age and IQ

Age

IQ

Score Distributions at Screening

Screening scores for every participant (rTMS_cohort); means and percentages are in Demographics, Table 1.

Hamilton Rating Scale for Depression

Clinical Global Impressions Scale

Clinician

Research assistant

Global Assessment of Functioning Scale

Beck Scale for Suicide Ideation

Columbia - Suicide Severity Rating Scale

1. Wish to be dead
2. Non-specific Active Suicidal Thoughts
3. Active Suicidal Ideation with Any Methods (Not a Plan) without Intent to Act
4. Active Suicidal Ideation with Some Intent to Act, without Specific Plan
5. Active Suicidal Ideation with Specific Plan and Intent

SRS-SF | Social Responsiveness Scale (self-report)

SBQ-R | Suicide Behaviors Questionnaire-Revised

Beck Depression Inventory

Generalized Anxiety Disorder Scale

Ruminative Response Scale

Reflection

Brooding

Clinical Scores Over Time

Mixed Effects Model

Who is shown. Participants who completed treatment. Each coloured line is one participant; the boxplots below each plot show the spread at every timepoint with the mean as a black line.

The trend line is a linear mixed-effects model

score = intercept + slope × weeks since first treatment + participant offset + error

• Why a mixed model and not an ordinary regression line. Each participant contributes up to ten scores, and scores from the same person are much more alike than scores from different people. The intraclass correlation (ICC) in each caption is that share: 0.13 to 0.73 here, so most of the spread in the plots is who the participant is, not when they were measured. An ordinary regression treats every score as a different person; it then overstates how precise the trend is, and participants with more visits pull the line towards themselves. The mixed model gives every participant their own starting level (the participant offset, a random intercept) and estimates the slope from how each person changes relative to themselves.
• The slope is the average change per week across participants. Letting each person also have their own slope (a random slope) is not attempted: with 17 completers it is unlikely to be estimated reliably.
• Note that the timepoints are not evenly spaced in time: the wait from screening to the first session ranges from 1 to 16 weeks, session 30 comes a median 6.1 weeks after the first session, and the 12-week follow-up a median 19 weeks after it. Time is measured from each participant’s first session (their earliest treatment date) using the assessment date of each score, so everyone is lined up on the treatment itself and screening falls at negative weeks. The intercept in the caption is the model’s score on the day of the first session.
• Why the line looks bent. The x axis keeps the visits evenly spaced so every visit is readable. The trend is a straight line in real weeks, drawn at each timepoint’s median week, so it bends where visits are far apart in time (screening, follow-up). Hover over the black line to see the week of each point. The grey band is the 95% confidence interval of the average trend.

Hamilton Rating Scale for Depression

Beck Scale for Suicide Ideation

Modified Patient Health Questionnaire-9

Self-report, at screening, every fifth session and the three follow-up visits. The form has no date of its own, so time is taken from the visit date.

Beck Depression Inventory

Self-report, at screening, the lead-in visit two weeks later and the three follow-up visits (not at treatment sessions).

Clinical Global (severity) Impressions Scale

Clinician

Rated by the study clinician at screening and the three follow-up visits.

Research assistant

Rated by the research assistant at every assessment visit.

Clinical Global (Improvement) Impressions Scale

CGI-I is rated against the participant’s condition at the previous visit (1 = very much improved, 4 = no change, 7 = very much worse), so it is already a change score and is not asked at screening. There is no trend line: a participant rated 3 at every visit is improving each time, which a fitted line would show as flat.

Clinician

Rated by the study clinician at the three follow-up visits.

Research assistant

Rated by the research assistant at every assessment visit after screening.

NIH Toolbox

Picture Vocabulary

Picture Seq Memory

List Sorting Working Memory

Flanker

Change Card Sort

Processing Speed

Oral Reading

Fluid Composite

Crystallized Composite

Total Composite

Early Childhood Composite

MRI Quality (MRIQC)

T1-weighted structural

CNR (Contrast-to-Noise Ratio): Reflects GM/WM contrast.
Higher is better; typical range: 1.5–2.5.

SNR (Signal-to-Noise Ratio): Overall image clarity relative to background noise.
Typical range: 25–40.

INU Median (Bias Field Inhomogeneity): Measures intensity non-uniformity; closer to 1 is ideal.
Typical range: 0.95–1.1.

CJV (Coefficient of Joint Variation): GM/WM intensity overlap; lower is better.
Typical range: 0.5–0.9.

BOLD resting state

FD Mean (Framewise Displacement): Average head motion per volume.
<0.2 mm is ideal; 0.1–0.3 mm is typical.

FD Num: Number of volumes with FD > 0.2 mm.
Lower is better; <20 common.

tSNR (Temporal SNR): Stability of voxel signal across time.
Higher is better; typical range: 50–100.

DVARS (Standardized): Change in signal between volumes; higher = more motion.
Values near 1 are typical.

Data Quality

Nothing is changed in REDCap: every check below lists what to correct there. Score values that are outside their valid range, not a number, or a REDCap missing-data code are left out of all tables, plots and models. The other checks only list records for the team to review. Forms are checked at every heatmap visit (screening once, for all participants).

Summary

Number of issues found by each check (green = none). Details are in the other tabs.

Check	Issues	Participants
Scores
Outside the valid range	1	1
Not a number, or a REDCap missing-data code	2	2
Total from a form not marked completed	48	19
REDCap forms
Marked completed, but no data entered	5	4
Data entered, but not marked completed	27	18
Marked not completed, but has data	3	3
Marked not completed, no reason given	3	3
Reason "Other" with no explanation	9	9
Forms REDCap doesn't export to the dashboard	0

Scores

Outside the valid range. The value is outside the range the form can produce (config/score_ranges.csv, with where each range comes from). Left out of every table, plot and model; correct it in REDCap.

Participant	Visit	Measure	Value	Valid range	Issue
RMA01_CMH_0027	Screening	HRSD-17 total (v2 form)	1017	0 to 52	Outside valid range

Not a number, or a REDCap missing-data code. Missing-data codes (e.g. NI, no information) are read as missing; anything else that isn’t a number should be corrected in REDCap. Both are left out.

Participant	Visit	Measure	Value	Issue
RMA01_CMH_0006	Screening	GAF	NI	REDCap missing-data code
RMA01_CMH_0005	Session 5	CGI-S (RA)	NI	REDCap missing-data code

Total from a form not marked completed. REDCap adds up whichever items were answered, so a partly scored form gives a lower total. These totals are used in the tables and plots; check that every item was scored, then mark the form completed (or correct it).

Participant	Visit	Measure	Value	Recorded
RMA01_CMH_0001	2weeks_post_screen_arm_1	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0002	12 Weeks Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0002	1 Week Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0002	2weeks_post_screen_arm_1	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0002	4 Weeks Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0003	12 Weeks Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0003	2weeks_post_screen_arm_1	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0004	12 Weeks Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0004	1 Week Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0004	2weeks_post_screen_arm_1	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0004	4 Weeks Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0005	2weeks_post_screen_arm_1	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0005	4 Weeks Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0006	1 Week Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0006	2weeks_post_screen_arm_1	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0006	4 Weeks Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0007	12 Weeks Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0007	1 Week Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0007	2weeks_post_screen_arm_1	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0007	4 Weeks Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0008	12 Weeks Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0008	1 Week Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0008	2weeks_post_screen_arm_1	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0008	4 Weeks Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0008	Screening	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0009	12 Weeks Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0009	1 Week Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0009	2weeks_post_screen_arm_1	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0009	4 Weeks Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0010	2weeks_post_screen_arm_1	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0015	12 Weeks Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0015	1 Week Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0017	1 Week Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0018	1 Week Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0018	2weeks_post_screen_arm_1	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0021	1 Week Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0021	4 Weeks Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0022	12 Weeks Post Treatment	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0022	2weeks_post_screen_arm_1	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0022	Screening	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0023	Screening	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0026	Screening	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0030	Screening	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0031	Screening	BDI-II total	0	REDCap: Incomplete (data entered)
RMA01_CMH_0005	Session 15	HRSD-17 total (old form)	15	completed: Partial
RMA01_CMH_0005	Session 20	HRSD-17 total (old form)	16	completed: Partial
RMA01_CMH_0005	Session 25	HRSD-17 total (old form)	16	completed: Partial
RMA01_CMH_0008	Screening	HRSD-17 total (old form)	3	completed: Partial

REDCap forms

Marked completed, but no data entered. The form says it was completed, but none of its answers are filled in (dates, rater and calculated fields don’t count). Enter the data or correct the completion answer.

Participant	Visit	Form	Recorded
RMA01_CMH_0001	4 Weeks Post Treatment	CGI (Clinician)	completed: Yes
RMA01_CMH_0022	MRI Visit 2	NIH Toolbox	completed: Yes
RMA01_CMH_0012	Screening	Assessment Summary	REDCap: Complete
RMA01_CMH_0022	Screening	Assessment Summary	REDCap: Complete
RMA01_CMH_0046	Screening	SCID-5-RV Score Sheet	completed: Yes

Data entered, but not marked completed. The form has answers but no completion answer (or REDCap status Incomplete). Shown as gold in the heatmaps; mark it completed or partial.

Participant	Visit	Form	Recorded
RMA01_CMH_0016	1 Week Post Treatment	SRS-SF - Self Report	REDCap: Incomplete (data entered)
RMA01_CMH_0016	1 Week Post Treatment	BDI-II	REDCap: Incomplete (data entered)
RMA01_CMH_0018	1 Week Post Treatment	SRS-SF - Self Report	REDCap: Incomplete (data entered)
RMA01_CMH_0018	1 Week Post Treatment	SRS-SF - Informant	REDCap: Incomplete (data entered)
RMA01_CMH_0021	1 Week Post Treatment	rTMS Follow Up Questionnaire	no completion recorded (form has data)
RMA01_CMH_0022	1 Week Post Treatment	rTMS Follow Up Questionnaire	no completion recorded (form has data)
RMA01_CMH_0037	1 Week Post Treatment	BRIEF-A - Self Report	REDCap: Incomplete (data entered)
RMA01_CMH_0011	12 Weeks Post Treatment	rTMS Follow Up Questionnaire	no completion recorded (form has data)
RMA01_CMH_0017	12 Weeks Post Treatment	M3VAS - Change	no completion recorded (form has data)
RMA01_CMH_0028	12 Weeks Post Treatment	BRIEF-A - Self Report	REDCap: Incomplete (data entered)
RMA01_CMH_0018	2 Weeks Post Screening	BDI-II	REDCap: Incomplete (data entered)
RMA01_CMH_0005	4 Weeks Post Treatment	SRS-SF - Self Report	REDCap: Incomplete (data entered)
RMA01_CMH_0011	4 Weeks Post Treatment	rTMS Follow Up Questionnaire	no completion recorded (form has data)
RMA01_CMH_0028	4 Weeks Post Treatment	rTMS Follow Up Questionnaire	no completion recorded (form has data)
RMA01_CMH_0001	Screening	GAD-7	REDCap: Incomplete (data entered)
RMA01_CMH_0002	Screening	GAD-7	REDCap: Incomplete (data entered)
RMA01_CMH_0002	Screening	BRIEF-2 - Self Report	REDCap: Incomplete (data entered)
RMA01_CMH_0004	Screening	ATHF | Antidepressant Treatment History	REDCap: Incomplete (data entered)
RMA01_CMH_0013	Screening	Randomization	REDCap: Incomplete (data entered)
RMA01_CMH_0014	Screening	VABS-3 | Vineland	no completion recorded (form has data)
RMA01_CMH_0016	Screening	MM-PHQ9	REDCap: Incomplete (data entered)
RMA01_CMH_0031	Screening	Informed Consent Checklist	REDCap: Incomplete (data entered)
RMA01_CMH_0033	Screening	Informed Consent Checklist	REDCap: Incomplete (data entered)
RMA01_CMH_0043	Screening	Assessment Summary	REDCap: Incomplete (data entered)
RMA01_CMH_0047	Screening	ATHF | Antidepressant Treatment History	REDCap: Incomplete (data entered)
RMA01_CMH_0031	Session 10	M3VAS - Change	no completion recorded (form has data)
RMA01_CMH_0031	Session 15	M3VAS - Change	no completion recorded (form has data)

Marked not completed, but has data. The form says it was not completed, yet has answers: it was probably partly completed.

Participant	Visit	Form	Recorded
RMA01_CMH_0002	Screening	Demographics	completed: No
RMA01_CMH_0026	Screening	Demographics	completed: No
RMA01_CMH_0033	Screening	Demographics	completed: No

Marked not completed, no reason given. The form says it was not completed but “Why was this form not completed?” is empty.

Participant	Visit	Form	Recorded
RMA01_CMH_0012	4 Weeks Post Treatment	C-SSRS	completed: No
RMA01_CMH_0003	Session 15	M3VAS - Change	completed: No
RMA01_CMH_0005	Session 30	CGI (RA)	completed: No

Reason “Other” with no explanation. The reason is “Other” but the explanation field is empty.

Participant	Visit	Form	Recorded
RMA01_CMH_0001	Screening	BSI | Beck Scale for Suicide Ideation	completed: No
RMA01_CMH_0003	Screening	BSI | Beck Scale for Suicide Ideation	completed: No
RMA01_CMH_0007	Screening	Pre-rTMS Questionnaire	completed: No
RMA01_CMH_0009	Screening	Pre-rTMS Questionnaire	completed: No
RMA01_CMH_0026	Screening	Pre-rTMS Questionnaire	completed: No
RMA01_CMH_0030	Screening	Pre-rTMS Questionnaire	completed: No
RMA01_CMH_0033	Screening	Pre-rTMS Questionnaire	completed: No
RMA01_CMH_0040	Screening	Pre-rTMS Questionnaire	completed: No
RMA01_CMH_0042	Screening	Pre-rTMS Questionnaire	completed: No

Forms REDCap doesn’t export to the dashboard. The dashboard’s API user has no export rights on these forms, so they are left out of the heatmaps. Ask the REDCap administrator for export rights.

Every form in the heatmaps is exported.